Les Barons de la Bourse

Heidi Kunz Fields

Age : 66

Patrimoine public : 7 805 374 USD

Principales sociétés :

Agilent Technologies, Inc. -

Icosavax, Inc. -

Phathom Pharmaceuticals, Inc.

Synthèse

Heidi Kunz Fields is on the board of Agilent Technologies, Inc., Phathom Pharmaceuticals, Inc. and Icosavax, Inc.

Ms. Fields previously was Chief Financial Officer & Executive Vice President for Gap, Inc., Chief Financial Officer of ITT Industries, Inc., Treasurer & Vice President of General Motors Corp. and Chief Financial Officer & Executive Vice President of Blue Shield of California.

Ms. Fields received an MBA from Columbia Business School and an undergraduate degree from Georgetown University.

Postes et responsabilités de Heidi Kunz Fields

Nom	Titre	Depuis
Agilent Technologies, Inc. (Equipement et technologie médicale avancés)	Independent Director	2000
Icosavax, Inc. (Recherche biotechnologique et médicale)	Independent Director	2021
Phathom Pharmaceuticals, Inc. (Recherche biotechnologique et médicale)	Independent Director	2019

Participations de Heidi Kunz Fields

Nom	Actions	%	Valorisation
Agilent Technologies, Inc. (A) (Equipement et technologie médicale avancés)	57 849	0,019%	6 899 650 USD
Avanos Medical, Inc. (AVNS) (Equipement, fournitures et distribution médicale)	28 885	0,061%	842 287 USD
Icosavax, Inc. (ICVX) (Recherche biotechnologique et médicale)	8 750	0,022%	63 438 USD
Phathom Pharmaceuticals, Inc. (PHAT) (Recherche biotechnologique et médicale)	0	0,0000%	0 USD

Heidi Kunz Fields: Réseau personnel

Nom	Sociétés liées
David A. Socks	Phathom Pharmaceuticals, Inc.
Rodney Gonsalves	Agilent Technologies, Inc.
Ami Shah Brown	Icosavax, Inc.
Daniel K. Podolsky	Agilent Technologies, Inc.
Darlene Solomon	Agilent Technologies, Inc.
Peter Kolchinsky	Icosavax, Inc.
Adam K. Simpson	Icosavax, Inc.
Kristin Giffin	Agilent Technologies, Inc.
Mark Stenhouse	Phathom Pharmaceuticals, Inc.
Katharine Knobil	Agilent Technologies, Inc.